Moderna Inc (NAS:MRNA)
$ 141.01 8.11 (6.1%) Market Cap: 54.04 Bil Enterprise Value: 43.65 Bil PE Ratio: 0 PB Ratio: 4.21 GF Score: 68/100

Moderna Inc at Needham Healthcare Conference Transcript

Apr 10, 2019 / 03:20PM GMT
Release Date Price: $26.8 (-0.07%)
Alan Carr
Needham & Company, LLC, Research Division - Senior Analyst

All right. Good morning, everyone. I'm Alan Carr. I've got Tal Zaks with me from Moderna, and we're delighted you could be here with us this morning.

Tal Zaks
Moderna, Inc. - Chief Medical Officer

Thank you. It's great to be here.

Questions & Answers

Alan Carr
Needham & Company, LLC, Research Division - Senior Analyst

So I want to go over -- we're going to cover a lot of topics. As I was just saying, there's a pretty broad investor base in Moderna, so I thought it makes sense to start off with some sort of big picture questions about mRNA and the technology and then go through some of the pipeline programs. But maybe we can just start off with some big picture thoughts on mRNA technology. Why is it different? And why has it been a challenge in the past to develop mRNA as a drug?

Tal Zaks
Moderna, Inc. - Chief Medical Officer

Thank you, Alan. Great to be here. So let me start with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot